Finance

Lists
Why is AARTIDRUGS up 3,13%?
Dive Deeper
AARTIDRUGS:NSE
Aarti Drugs Ltd
428,00 ₹
+3,13%
(+13,00) 1D
6 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AARTIDRUGS...
Open
421,15 ₹
High
430,25 ₹
Low
414,10 ₹
Mkt. cap
39,63 млрд
Avg. vol.
182,97 м.
Volume
132,86 м.
Dividend
0,47%
Quarterly dividend
0,50 ₹
Ex-dividend date
2026 ж. 09 ақп.
P/E ratio
20,44
52-wk high
534,00 ₹
52-wk low
318,95 ₹
EPS
20,94 ₹
Shares outstanding
23,58 млн
No. of employees
1 мың
Open
421,15 ₹
High
430,25 ₹
Low
414,10 ₹
Mkt. cap
39,63 млрд
Avg. vol.
182,97 м.
Volume
132,86 м.
Dividend
0,47%
Quarterly dividend
0,50 ₹
Ex-dividend date
2026 ж. 09 ақп.
P/E ratio
20,44
52-wk high
534,00 ₹
52-wk low
318,95 ₹
EPS
20,94 ₹
Shares outstanding
23,58 млн
No. of employees
1 мың
News stories
From web sources and news partners
About Aarti Drugs Ltd
CEOPrakash M. Patil
Employees1,36 мың
Founded1984
Headquarters-
SectorPharmaceutical industry
Websiteaartidrugs.co.in
Last report
2026 ж. 03 там.
Fiscal period
Q1 2027
EPS / Est. (INR)
5,66 ₹ / 5,40 ₹
+4,86%beat
Revenue / Est. (INR)
7,03 млрд / 6,66 млрд
+5,46%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
6,53 млрд
6,02 млрд
7,20 млрд
7,03 млрд
Cost of goods sold
4,08 млрд
3,87 млрд
4,75 млрд
4,28 млрд
Cost of revenue
4,08 млрд
3,87 млрд
4,75 млрд
4,28 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
330,70 млн
331,60 млн
353,24 млн
365,10 млн
Operating expense
1,76 млрд
1,77 млрд
1,69 млрд
1,95 млрд
Total operating expenses
5,85 млрд
5,63 млрд
6,44 млрд
6,22 млрд
Operating income
681,20 млн
383,20 млн
761,27 млн
805,50 млн
Other non operating income
-91,00 мың
16,00 мың
12,15 млн
-
EBT including unusual items
604,11 млн
290,32 млн
703,57 млн
692,40 млн
EBT excluding unusual items
604,11 млн
290,32 млн
703,57 млн
713,30 млн
Income tax expense
152,50 млн
-115,20 млн
150,94 млн
191,10 млн
Effective tax rate
25,24%
-39,68%
21,45%
27,60%
Other operating expenses
1,27 млрд
1,26 млрд
1,16 млрд
1,40 млрд
Net income
452,80 млн
405,40 млн
551,97 млн
501,70 млн
Net profit margin
6,94%
6,74%
7,66%
7,14%
Earnings per share
4,95
-
-
5,66
Interest and investment income
-
-
11,69 млн
-
Interest expense
-77,00 млн
-92,90 млн
-81,55 млн
-92,20 млн
Net interest expenses
-77,00 млн
-92,90 млн
-69,85 млн
-92,20 млн
Depreciation and amortization charges
162,60 млн
179,50 млн
180,41 млн
184,60 млн
EBITDA
836,10 млн
515,81 млн
916,49 млн
972,92 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары